Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 115567
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115567
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115567
Table 1 Summarize the research on the effects of some drugs and therapies on postoperative neurocognitive disorder
| Drugs/therapies | Target | Pathway | Effect | Ref. |
| MCC950 | NLRP3 | NLRP3 inflammasome pathway | Reduce the expression of pro-inflammatory cytokines and relieve neuroinflammation | [132] |
| Atorvastatin | NLRP3 | NLRP3 inflammasome pathway, NF-κB pathway | Play a neuroprotective role | [133] |
| IL-6 blocking therapy | IL-6 | Reduce the expression of proinflammatory cytokine IL-6 and play a neuroprotective role | [88] | |
| Maraviroc | CCR5/cAMP response element binding protein/NLRP1 | CCR5/cAMP response element binding protein/NLRP1 pathway | Reduce neuroinflammation and improve cognitive impairment | [135] |
| Celastrol | Caspase-3/gasdermin E | cGAS-STING signaling pathway | Improving cognitive performance of POCD mice | [96] |
| Melatonin | Matrix metalloproteinase-9 | Inflammatory pathway | Reduce neuroinflammation and synaptic dysfunction, improve delirium like behavior | [45] |
| Lactic acid | SIRT1 | SIRT1 pathway | Improve POCD | [136] |
| Resveratrol | SIRT1 | SIRT1 pathway, NF-κB pathway | Regulate microtubule function | [21] |
| Nrf2 activator | Nrf2 | Inhibit neuroinflammation, promote neurogenesis, and improve cognitive function | [20,70] | |
| Irisin | Microglia | Reprogramming microglia as anti-inflammatory M2 phenotype to prevent POCD | [19] | |
| Galantamine | Cholinesterase | Cholinergic anti-inflammatory pathway | Restore the function of astrocytes and synapses | [137] |
| Varenicline | Tau protein | Reduce tau protein mislocalization, DNA damage and neuronal apoptosis, and improve cognition | [138] | |
| Ginsenoside Rg1 | Endocytosis lysosomal pathway | Eliminating β-amyloid and alleviating cognitive and synaptic deficits in elderly POCD mice | [139] | |
| Probiotics | NLRP3 | NLRP3 inflammasome pathway | Reduce the incidence of POCD in elderly patients. Reduce the incidence of POCD in elderly patients | [51,52] |
| Extracellular vesicles | Deliver therapeutic molecules to achieve precise treatment of central lesion area | [43,59] | ||
| Intranasal insulin | P3R/glucose-regulated protein 75/voltage-dependent anion channel 1 | Phosphoinositide 3-kinases/protein kinase B signaling pathway | Reduce the level of proinflammatory cytokines and play a neuroprotective role | [76,142] |
| Coenzyme Q10 | Mitochondria | Alleviate memory deficits | [143] | |
| WS635 | Mitochondria | Reduce synaptic damage and mitochondrial dysfunction | [144] | |
| Elamipretide | NLRP3 | NLRP3 inflammasome pathway | Restore damaged mitochondrial and synaptic functions | [145] |
| Lomastatin | Improve synaptic defects of neurons | [146,147] | ||
| Electroacupuncture | Multiple pathways | Neuroprotective effect | [71,150-152] | |
| Vagus nerve stimulation | Acetylcholine | Cholinergic anti-inflammatory pathway | Exert anti-inflammatory effect | [57] |
| Preoperative and postoperative intervention | PPAR-gamma coactivator-1α/brain-derived neurotrophic factor pathway | Improving cognitive and inflammatory status in aged mice | [153] | |
| Environmental enrichment | Reduce cognitive impairment and neuroinflammation caused by anesthesia/surgery | [155-157] |
- Citation: Jie Y, Lai ZW, Zhou W, Li YC, Zhong BL, Zeng XX, Jiang Q. Neuroimmune synapse and modulation by anesthetics: Inflammatory mechanisms and therapeutic perspectives for postoperative neurocognitive disorders. World J Psychiatry 2026; 16(4): 115567
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/115567.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.115567
